Preoperative Chemotherapy plus Lapatinib or Trastuzumab or Both in HER2-Positive Operable Breast Cancer (CHERLOB Trial)Valentina Guarneri, PierFranco Conte, Federico Piacentini et al.|Clinical Breast Cancer|2008Cited by 30